1. Predictors of outcome and different management of aortobronchial and aortoesophageal fistulas 
Victor X. Mosquera, MD, PhD, Milagros Marini, MD, PhD, Francisco Pombo-Felipe, MD, PhD, Pablo Gómez-Martinez, MD, Carlos Velasco, MD, José M. Herrera-Noreña, MD, PhD, José J. Cuenca-Castillo, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 148, Issue 6, Pages e2 (December 2014)
DOI: /j.jtcvs
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Cumulative survival for all aortic fistulas (n = 26), aortobronchial fistulas (ABF), and aortoesophageal fistulas (AEFs). Better survival was seen for those with ABFs; however, this difference did not reach statistical significance. No deaths occurred after 3 months.
The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

3. Figure 2
Survival stratified by surgical management type. The patients who had undergone open repair (n = 7) had greater long-term survival than those who had undergone thoracic endovascular aortic repair (TEVAR) (n = 8; P = .04). The median follow-up of the surviving patients was 31 months (range, 2-180; interquartile range, 100).
The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

4. Figure E1
The flowchart depicts the modification in patient treatment since the incorporation of emergency aortic endografting at our institution. In the 1998 to 2003 period, 1 patient had an aortoesophageal fistulas (AEF), whose primary intended treatment was urgent thoracic endovascular aortic repair (TEVAR), but who had died waiting for the arrival of an appropriate size thoracic aortic stent-graft.
The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions